Stock Evaluator: Anteris Technologies Global Corp. (AVR)

Anteris Technologies Global Corp. AVR

$7.84 -0.40 -4.85%
July 31, 2026 4:00:00 PM EST November 10, 2021 Volume: 1,034,876
After Hours: $120.37   0.15  |  0.12% November 10, 2021 7:59 PM EST Volume: 72,713
USD NASD | DELAYED PRICE
SECTOR INDUSTRY
Health Care Health Care Equipment & Supplies

A+ Stock Grade Summary:

VALUE:
GROWTH:
MOMENTUM:
EPS REVISIONS:
QUALITY:
COMPANY SUMMARY
Anteris Technologies Global Corp., a structural heart company, develops and commercializes minimally invasive medical devices to treat heart valve diseases. It offers the DurAVR transcatheter heart valve system, a novel transcatheter aortic valve for the treatment of severe aortic stenosis that is shaped to mimic the performance of a healthy human aortic valve. The company also develops ADAPT anti-calcification tissue, an anti-calcification preparation which transforms xenograft tissue into durable bioscaffolds that are used to mimic human tissue for surgical repair in multiple settings, including aortic valve replacement; and ComASUR delivery system, a physician-developed balloon expandable delivery system that contains a reinforced steerable catheter for a precise deflection through the heart anatomy in a controlled manner to avoid damage to the aorta. Anteris Technologies Global Corp. is based in Toowong, Australia.

Commentary & Analysis


Financial Summary

Share Statistics AVR Industry
Median
Percentile
(All Stocks)
Market Cap (Mil) $764.1 $337.2 42%
Shares Out (Mil) 83.0 41.9 59%
Institutional Ownership 95.2% 77.8% 67%
Float (Mil) 60.4 34.7 52%
Beta na 0.85 na
Avg Daily Volume (000s) 936 278 69%
Price Change
(52-week)
135.4% 58.7% 95%
Growth AVR Industry
Median
Percentile
(All Stocks)
Sales (5yr) (19.2%) 11.8% 3%
Net Income (5yr) (51.5%) (5.8%) 7%
EPS (5yr) (5.1%) 11.4% 25
Dividends (5yr) 0.0% 0.0% 0%
Cash Flow (5yr) (15.0%) (16.3%) 52%
Estimates Qtrly Current
Fiscal
Year
Next
Fiscal
Year
# of Estimates 3 3 3
Current EPS ($0.207) ($1.080) ($0.980)
Month Ago EPS ($0.207) ($1.080) ($0.980)
# Rev Up 0 0 0
# Rev Down 1 1 1
Three Months Ago EPS ($0.185) ($0.873) ($0.970)
Year/Year Chg (25.3%) (57.7%) (68.0%)
Financials AVR Industry
Median
Percentile
(All Stocks)
Sales (TTM) (Mil) $2 $152 3%
Net Income (TTM) (Mil) ($95) ($10) 11%
EPS (TTM) ($1.959) ($0.500) 15%
Operating Cash Flow (TTM) (Mil) ($85) ($2) 6%
Net Cash Flow (TTM) (Mil) $234 $1 86%
Long-Term Debt (Q1) (Mil) $2 $22 21%
Enterprise Value (Q1) (Mil) $673 $304 37%
Valuation AVR Industry
Median
Percentile
(All Stocks)
P/B 2.74 2.80 62%
P/E na 31.1 na
Dividend Yield 0.0% 0.0% 0%
PEG (5yr hist) na 1.9 na
Ratios AVR Industry
Median
Percentile
(All Stocks)
Gross Margin 74.3% 59.1% 85%
Net Margin na (7.3%) na
ROA (53.9%) (13.7%) 11%
ROE (59.2%) (15.8%) 14%
Liabilities to Assets 5.5% 44.7% 3%
F-Score 4 4 34%

Anteris Technologies Global Corp. did not pass any screens on 7/31/2026.

Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.

Ⓒ 2026 American Association of Individual Investors